Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 19617 NEW YORK, NY
Back to TSHA Full portfolio

Position in TSHA

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$5,218,378
+$1,844,505 QoQ
Shares Held
766,282
+1.5% QoQ
Ownership
0.235%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 208 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 87% Shared 0% None 13%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,254,031 across 424 Biotechnology names. TSHA ranks #111 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in TSHA

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,218,378 766,282
2026-03-31 $3,373,873 754,782
2025-12-31 $4,259,266 774,412
2025-09-30 $968,717 296,244
2025-06-30 $514,318 222,649
2025-03-31 $1,394,261 1,003,067
2024-12-31 $4,573,694 2,643,755
2024-09-30 $6,032,807 3,001,397
2024-06-30 $6,638,356 2,963,553
2024-03-31 $269,036 93,741
2023-12-31 $64,576 36,484
2023-09-30 $432 137
2023-06-30 $1,177 1,782
2023-03-31 $1,422 1,782
2022-12-31 $4,027 1,782
2022-09-30 $85,996 44,558
2022-06-30 $1,038,962 279,291
2022-03-31 $2,867,520 439,804
2021-12-31 $2,767,560 237,559
2021-09-30 $7,827,138 420,362
2021-06-30 $4,529,293 213,646
2021-03-31 $532,325 26,223
2020-12-31 $630,271 23,748